Literature DB >> 9514574

Characterisation and molecular typing of Burkholderia pseudomallei: are disease presentations of melioidosis clonally related?

R Norton1, B Roberts, M Freeman, M Wilson, C Ashhurst-Smith, W Lock, D Brookes, J La Brooy.   

Abstract

Eighteen cases of culture positive melioidosis caused by Burkholderia pseudomallei, were seen in four geographically separate communities in North Queensland, Australia. The genetic inter-relatedness of the clinical isolates were compared utilising random amplification of polymorphic DNA (RAPD) and multilocus enzyme electrophoresis (MEE). The isolates segregated into two groups that correlated with clinical presentation rather than geographical location. This is the first described association between the varied clinical presentations of this condition and specific molecular type. If proven on larger studies, this may further our understanding of the pathogenesis of this important condition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514574     DOI: 10.1111/j.1574-695X.1998.tb01109.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  10 in total

1.  Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei.

Authors:  Peter Lowe; Catherine Engler; Robert Norton
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  Isolates of Burkholderia pseudomallei from Northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation.

Authors:  Allen C Cheng; Daniel Godoy; Mark Mayo; Daniel Gal; Brian G Spratt; Bart J Currie
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

Review 3.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Variation in the spacer regions separating tRNA genes in Renibacterium salmoninarum distinguishes recent clinical isolates from the same location.

Authors:  S M Alexander; T H Grayson; E M Chambers; L F Cooper; G A Barker; M L Gilpin
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

5.  Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei.

Authors:  G C Ulett; N Ketheesan; R G Hirst
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

6.  The epidemiology of melioidosis in the Balimo region of Papua New Guinea.

Authors:  J M Warner; D B Pelowa; D Gal; G Rai; M Mayo; B J Currie; B Govan; L F Skerratt; R G Hirst
Journal:  Epidemiol Infect       Date:  2007-08-22       Impact factor: 2.451

7.  Multilocus sequence types of clinical Burkholderia pseudomallei isolates from peninsular Malaysia and their associations with disease outcomes.

Authors:  Abdel Rahman Zueter; Zaidah Abdul Rahman; Mahmoud Abumarzouq; Azian Harun
Journal:  BMC Infect Dis       Date:  2018-01-02       Impact factor: 3.090

8.  Clinical, Bacteriologic, and Geographic Stratification of Melioidosis Emerges from the Sri Lankan National Surveillance Program.

Authors:  Harindra D Sathkumara; Adam J Merritt; Enoka M Corea; Shivankari Krishnananthasivam; Mohan Natesan; Timothy J J Inglis; Aruna Dharshan De Silva
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

9.  Source-identifying biomarker ions between environmental and clinical Burkholderia pseudomallei using whole-cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).

Authors:  Suthamat Niyompanich; Janthima Jaresitthikunchai; Kitima Srisanga; Sittiruk Roytrakul; Sumalee Tungpradabkul
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

Review 10.  The epidemiology and clinical spectrum of melioidosis in a teaching hospital in a North-Eastern state of Malaysia: a fifteen-year review.

Authors:  AbdelRahman Zueter; Chan Yean Yean; Mahmoud Abumarzouq; Zaidah Abdul Rahman; Zakuan Z Deris; Azian Harun
Journal:  BMC Infect Dis       Date:  2016-07-16       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.